Deep learning enhances risk stratification accuracy to 92% in atherosclerosis using multiple imaging types, suggesting a new clinical decision tool.
Introduction Atherosclerosis is a leading cause of cardiovascular events, requiring accurate risk stratification. Traditional methods rely on subjective imaging and clinical scores, limiting precision. Material and methods We developed a deep learning (DL) model combining U-Net for lesion segmentation, ResNet for classification, and an attention mechanism to enhance detection of high-risk plaques. Multimodal data—including ultrasound, CTA, and clinical variables—underwent standard preprocessing. The dataset was split (8:1:1) and evaluated using 5-fold cross-validation. Results The U-Net achieved a Dice coefficient of 0.88. The ResNet, integrated with clinical features, reached 92% classification accuracy and an AUC of 0.97. The attention mechanism improved vulnerable plaque detection by 10%. Grad-CAM visualizations showed 85% agreement with expert annotations. Processing time was reduced by 70% compared to traditional assessment methods. Multicenter validation confirmed strong generalizability. Conclusions This study constructed a multimodal DL model that significantly enhances the clinical value of atherosclerosis risk stratification, the prediction accuracy increased to 92% with an AUC of 0.97, and the average processing time per case was reduced from 6.3 ± 1.4 minutes to 1.9 ± 0.4 minutes (a reduction of approximately 70%). The model demonstrated higher precision in both lesion segmentation and high-risk plaque identification, providing clinicians with a rapid and reliable decision-support tool that is expected to further optimize individualized intervention strategies and improve patient prognosis.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: